Investor
Disclosure of information
- Sort by : Newest
-
2024
-
2023
-
Perubahan Kegiatan Usaha, 28 April 2023
Keterbukaan Informasi Kepada Pemegang Saham ini (selanjutnya akan disebut “Keterbukaan Informasi”) memuat informasi tentang rencana perubahan kegiatan usaha Perseroan berupa penambahan kegiatan usaha baru Perseroan di bidang perdagangan besar dan karenanya akan mengubah ketentuan Pasal 3 Anggara... more..
-
BOD Resignation, 20 October 2022, 20 October 2022
Keterbukaan Informasi PT Taisho Pharmaceutical Indonesia Tbk (“Perseroan”) Dalam rangka memenuhi ketentuan Pasal 9 Peraturan Otoritas Jasa Keuangan Nomor 33/POJK.04/2014 tentang Direksi dan Dewan Komisaris Emiten atau Perusahaan Publik (“POJK 33/2014”), dengan ini kami mengumumkan bahwa pada... more..
-
BOD Resignation September 2022, 29 September 2022
Keterbukaan Informasi PT Taisho Pharmaceutical Indonesia Tbk (“Perseroan”) Dalam rangka memenuhi ketentuan Pasal 9 Peraturan Otoritas Jasa Keuangan Nomor 33/POJK.04/2014 tentang Direksi dan Dewan Komisaris Emiten atau Perusahaan Publik (“POJK 33/2014”), dengan ini kami mengumumkan bahwa pada... more..
-
BOD Resignation May 2020, 15 May 2020
Disclosure of Information PT Taisho Pharmaceutical Indonesia Tbk (the “Company”) For the purpose of compliance with the provision of Article 9 of the Regulation of Financial Services Authority Number 33/POJK.04/2014 regaring the Board of Directors and Board of Commissioners of Issuers or Public ... more..
-
BOD Resignation 2020, 04 March 2020
Disclosure of Information PT Taisho Pharmaceutical Indonesia Tbk (the “Company”) For the purpose of compliance with the provision of Article 9 of the Regulation of Financial Services Authority Number 33/POJK.04/2014 regaring the Board of Directors and Board of Commissioners of Issuers or Public ... more..
-
Delisting Information, 23 March 2018
DISCLOSURE OF INFORMATION PT. Taisho Pharmaceutical Indonesia Tbk(the “Company”) Line of Business:Pharmaceutial Industry, Phone:+62 21 520 6720, Faks:+62 21 520 6735 For the purpose of compliance with the Financial Services Authority Regulation Number 31/POJK.04/2015 on Disclosure of Material I... more..
-
Shares Purchase Offering, 25 December 2017
ANNOUNCEMENT Share Purchase Period 18 – 22 December 2017 Payment Date 3 January 2018 SHARES PURCHASE OFFERING PT. Taisho Pharmaceutical Indonesia Tbk (the “Company”) Domiciled in South Jakarta Line of Business: Pharmaceutical Industry Head Office: Wisma Tamara Lt. 10, Jl.Jend. Sudirman Kav.... more..
-
BOD Resignation, 02 November 2016
DISCLOSURE OF INFORMATION PT. TAISHO PHARMACEUTICAL INDONESIA TBK -It is hereby announced than on 31 October 2016 the Board of Directors of PT. Taisho Pharmaceutical Indonesia Tbk, domiciled in South Jakarta and having its address at Tamara Center Building, 10th Floor, Jl. Jenderal Sudirman Kav. ... more..